收藏切换
Pharmacokinetic study of high fat diet on oral administration of FM888 in Chinese healthy participants
收藏切换
PDF
Yan JIANG1, Fang TIAN2, 3, Jian-ren ZHOU4, Yuan-yuan LI2, Wei WANG2, 3, Hua XU2, Lin-yan GAO1, Heng-yan QU1, 2
Chinese Journal of Clinical Pharmacology | 2026, 42(8) : 1170 - 1175
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(8): 1170-1175
Pharmacokinetics and Bioequivalence Study
Pharmacokinetic study of high fat diet on oral administration of FM888 in Chinese healthy participants
Full
Yan JIANG1, Fang TIAN2, 3, Jian-ren ZHOU4, Yuan-yuan LI2, Wei WANG2, 3, Hua XU2, Lin-yan GAO1, Heng-yan QU1, 2
Affiliations
  • 1.Clinical Research Center, Xuan Wu Hospital, Capital Medical University, Beijing 100053
  • 2.Beijing Tiantan Hospital, Capital Medical University, Beijing 100050
  • 3.Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • 4.Qingdao Yongzhan Pharmaceutial Technology Co., Ltd, Qingdao 266100, Shandong Province, China
Published: 2026-04-28 doi: 10.13699/j.cnki.1001-6821.2026.08.019
Outline
收藏切换
Objective

To assess the tablet effect of a high-fat diet on the pharmacokinetics of oral FM888 tablet in healthy Chinese participants. FM888 tablet is a novel highly selective adenylyl cyclase 1 (AC1) antagonist potentially involved in chronic pain treatment by modulation of central plasticity.

Methods

A single-center, open-label, randomized, single-dose, two-period crossover trial was conducted. Subjects were randomized 1∶1 to receive 400 mg FM888 tablet under fasting or high-fat meal conditions, then crossed over after a 7-day washout. Plasma FM888 concentrations were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and analyzed by non-compartmental methods using Phoenix WinNonlin 8.3.1.

Results

The Cmax of FM888 tablet in the fasting state and after a highfat meal were (175.57±89.51) and (63.74±38.74) ng·mL-1, respectively; AUC0-last were (645.84±355.50) and (416.28±245.83) h·ng·mL-1, respectively; AUC0-∞ were (698.22±373.46) and (455.36±290.66) h·ng·mL-1, respectively. Exposure to FM888 tablet was lower under fed conditions than under fasting conditions, with Cmax and AUC0-last reduced to approximately 36.00% and 65.00% of the fasting values, respectively. The geometric mean ratios (fed/fasting) for Cmax、AUC0-last and AUC0-∞ were 36.86% [90% confidence interval (CI): 28.94%-46.95%], 66.01% (90% CI: 55.72%-78.20%), and 67.39% (90% CI: 55.70%-81.53%), respectively. Mixed-effects modeling confirmed a significant effect of feeding status on key parameters (P<0.05). FM888 tablet was well tolerated; all adverse events were grade 1, with no serious events.

Conclusion

A high-fat meal significantly reduced FM888 bioavailability, indicating a marked food effect. Despite lower exposure, FM888 tablet demonstrated favorable safety and tolerability.

FM888 tablet  /  chronic pain  /  high-fat diet  /  pharmacokinetics  /  food effect
Yan JIANG, Fang TIAN, Jian-ren ZHOU, Yuan-yuan LI, Wei WANG, Hua XU, Lin-yan GAO, Heng-yan QU. Pharmacokinetic study of high fat diet on oral administration of FM888 in Chinese healthy participants[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (8) : 1170 -1175 . DOI: 10.13699/j.cnki.1001-6821.2026.08.019
Year 2026 volume 42 Issue 8
PDF
197
31
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.08.019
  • Receive Date:2025-12-17
  • Online Date:2026-08-06
  • Published:2026-04-28
Article Data
Affiliations
History
  • Received:2025-12-17
Affiliations
    1.Clinical Research Center, Xuan Wu Hospital, Capital Medical University, Beijing 100053
    2.Beijing Tiantan Hospital, Capital Medical University, Beijing 100050
    3.Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
    4.Qingdao Yongzhan Pharmaceutial Technology Co., Ltd, Qingdao 266100, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.08.019
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT